Disable ads (and more) with a membership for a one time $4.99 payment
Which outcome is associated with the interaction of Warfarin and CYP2C9 inducers?
Bleeding risk
Clotting risk
No significant outcome
Increased blood pressure
The correct answer is: Clotting risk
The interaction of Warfarin and CYP2C9 inducers can increase the risk of clotting, not bleeding. This is because Warfarin is a blood thinner, so when it is mixed with a drug that increases the activity of CYP2C9 enzymes, it can cause too much clotting in the blood. This is why options A, C, and D are incorrect, as they do not accurately reflect the interaction and its resulting outcome.